ArticleHaematologica2025

Rituximab maintenance after bendamustine-based treatment for follicular lymphoma and mantle cell lymphoma may exert a negative influence on SARS-CoV-2 infection outcomes.

Ángel Serna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.